- Poster presentation
- Open Access
Phase II trial designs for complex interventions: a single-arm single-stage design for clustered continuous outcomes
© Wilson et al. 2015
Published: 16 November 2015
To incorporate formal assessments of potential efficacy into feasibility and pilot studies of complex interventions, appropriate methods for sample size determination are required. In particular, the implications of clustered patient outcomes resulting from cluster randomisation or treatment provision must be addressed. In this paper we will show how small-sample methods used to design phase II drug trials can be extended to allow for this clustering. In particular, we will propose a single-arm single-stage design for continuous data clustered in a two-level hierarchical structure. A number of alternative methods for determining the choice of sample size will be described. We will report the results of a simulation study comparing these methods in terms of the resulting error rates, suggested sample size parameters, and computational burden. A sensitivity analysis will demonstrate the implications of nuisance parameter misspecification at the design stage. Particular attention will be given to the scenario where the number of cluster-level units is severely limited, as will often be the case in the early phases of complex intervention development and evaluation.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.